Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Connection

Search Results to Laura Hutchins

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following items that are connected to Hutchins, Laura

Item TypeName
Academic Article Impact of the year 2000 Medicare policy change on older patient enrollment to cancer clinical trials.
Academic Article Telomerase RNA deficiency in peripheral blood mononuclear cells in X-linked dyskeratosis congenita.
Academic Article Late cardiac effects of adjuvant chemotherapy in breast cancer survivors treated on Southwest Oncology Group protocol s8897.
Academic Article Treatment quality and outcomes of African American versus white breast cancer patients: retrospective analysis of Southwest Oncology studies S8814/S8897.
Academic Article Manganese superoxide dismutase polymorphism, treatment-related toxicity and disease-free survival in SWOG 8897 clinical trial for breast cancer.
Academic Article Nitric oxide synthase variants and disease-free survival among treated and untreated breast cancer patients in a Southwest Oncology Group clinical trial.
Academic Article A prospective analysis of the influence of older age on physician and patient decision-making when considering enrollment in breast cancer clinical trials (SWOG S0316).
Academic Article Gene polymorphisms in cyclophosphamide metabolism pathway,treatment-related toxicity, and disease-free survival in SWOG 8897 clinical trial for breast cancer.
Concept Carboplatin
Academic Article (SWOG) Pharmacogenetics and breast cancer treatment outcomes: results on oxidative stress-related genotypes (MPO, MnSOD) from a southwest oncology group intergroup trial (INT-01012)
Academic Article Phase II trial of biochemotherapy with interferon alpha, dacarbazine, cisplatin and tamoxifen in metastatic melanoma: a Southwest Oncology Group trial
Academic Article Comprehensive Geriatric Oncology. L Balducci, GH Lyman, WB Ershler, et al, editors
Academic Article Myeloperoxidase genotypes and enhanced efficacy of chemotherapy for early-stage breast cancer in SWOG-8897
Academic Article The influence of older age on physician and patient decision-making regarding enrollment to breast cancer clinical trials
Academic Article Regression of orbital and choroidal metastases from melanoma after treatment with vemurafenib.
Academic Article Treatment of metastatic melanoma with pazopanib: A report of five patient cases.
Academic Article Metastatic melanoma with dedifferentiation and extensive rhabdomyosarcomatous heterologous component.
Grant CFDA # 93.395SWOG 0709,Federal funding- A PHASE II SELECTION DESIGN OF PHARMACODYNAMIC SEPARATION OF CARBOPLATIN/PACLITAXEL/ERLOTINIB OR ERLOTINIB ALO
Grant SWOG 0819, A Randomized, Phase III Study Comparing Carboplatin/Paclitaxel Or Carboplatin/Paclitaxel/Bevacizumab With Or Without Concurrent Cetuximab i
Grant A Phase III Randomized, Placebo-Controlled Trial of Carboplatin and Paclitaxel with or without the PARP Inhibitor Verliparib (ABT-888) in Metastatic or Locally Advanced Unresectable BRCA-Associated Breast Cancer
Grant “A Randomized, Phase 2 Study of the Efficacy and Tolerability of Veliparib in Combination with Temozolomide or Veliparib in Combination with Carboplat
Academic Article Germline Genetic Variants in GATA3 and Breast Cancer Treatment Outcomes in SWOG S8897 Trial and the Pathways Study.
Academic Article Phase III Study of Adjuvant Ipilimumab (3 or 10 mg/kg) Versus High-Dose Interferon Alfa-2b for Resected High-Risk Melanoma: North American Intergroup E1609.
Academic Article Immune adverse events (irAEs) with adjuvant ipilimumab in melanoma, use of immunosuppressants and association with outcome: ECOG-ACRIN E1609 study analysis.

Search Criteria
  • Carboplatin